Andrews joins Akcea as CMO; plus changes at Strongbridge, Abeona, Lyra, Kronos and more

Akcea Therapeutics Inc. (NASDAQ:AKCA) said William Andrews will succeed Louis O’Dea as CMO. Andrews joins the rare disease company from Acer Therapeutics Inc. (NASDAQ:ACER), where he was CMO.

Rare disease company Strongbridge Biopharma plc (NASDAQ:SBBP)

Read the full 348 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE